Transition Metal Dichalcogenides in Biomedical Devices and Biosensors: A New Frontier for Precision Healthcare

This is the authors' abstract. We don't add key points for this paper.

Transition metal dichalcogenides (TMDs) have emerged as groundbreaking materials in the field of biomedical applications, particularly in the development of biosensors and medical devices. Their unique electronic and optical properties, combined with their tunability and biocompatibility, position TMDs as promising candidates for enhancing early disease detection and enabling personalized medicine. This perspective explores the multifaceted potential of TMDs, highlighting their applications in fluorescence and Raman-based biosensing, wearable and implantable devices, and smart therapeutic systems for targeted treatment. Additionally, we address critical challenges such as regulatory hurdles, long-term stability, and ethical considerations surrounding continuous health monitoring and data privacy. Looking to the future, we envision TMDs playing a vital role in the advancement of precision medicine, facilitating real-time health monitoring and individualized treatments. However, the successful integration of TMDs into clinical practice necessitates interdisciplinary collaboration among materials science, bioengineering, and clinical medicine. By fostering such collaboration, we can fully harness the capabilities of TMDs to revolutionize healthcare, making it more accessible, precise, and personalized for patients worldwide.